← Back to Akums Drugs & Pharmaceuticals Ltd Overview

📊Financials 📈PE Ratio 🥧Shareholding 💰Dividend 📋Quarterly ⚖️Balance Sheet 💹P&L 🌊Cash Flow

AKUMSPharmaceuticals

Akums Drugs & Pharmaceuticals Ltd — Financial Ratios & Key Metrics

₹466.10

-3.81%

P/E Ratio21.76xIndustry: 31.77x

ROE17.19%Return on equity

ROCE16.20%Return on capital

Debt/Equity0.03Low debt

💎

Valuation & Profitability

P/E Ratio

21.76x

Industry Average P/E

31.77x

Dividend Yield

0.00%

Market Cap

₹6.70K (Cr)

Sales Growth 5Y

11.27%

Profit Growth 5Y

48.93%

EPS Growth 5Y

-42.93%

OPM 5Y Avg

5.62%

📉

Price Returns

1 Month

-7.81%

3 Months

-10.14%

6 Months

-23.34%

1 Year

-29.80%

52W Low

₹405

Current

₹466

52W High

₹623

28% of 52-week range — Near lows

🔬

Technical Indicators

Neutral

Momentum is balanced — neither overbought nor oversold.

SMA 50

₹464

▲ Price above SMA 50 — Bullish

SMA 200

₹477

▼ Long-term downtrend

Volume Signal

126% of avg

Above average volume — strong conviction behind price move

Technical indicators are for educational purposes only. Not investment advice.

More on Akums Drugs & Pharmaceuticals Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.